Recombinant Human Mago nashi homolog 2 protein (His tag N-Terminus)
Be the first to review this product! 리뷰 제출
|
(0 출판물)
Recombinant Human Mago nashi homolog 2 protein (His tag N-Terminus) is a Human Full Length protein, in the 1 to 148 aa range, expressed in Escherichia coli, with >90%, suitable for SDS-PAGE, Mass Spec.
대체 명칭 보기
MAGOH2, MAGOHB, Protein mago nashi homolog 2
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human Mago nashi homolog 2 protein (His tag N-Terminus) (AB156754)
15% SDS-PAGE analysis of ab156754 (3µg).
Reactivity 정보
서열 정보
특성 및 보관 정보
제형
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MAGOH2 plays a significant role in RNA processing and development. It is part of the exon junction complex which influences mRNA splicing export and surveillance. This protein interacts closely with Y14 and other factors to regulate stable mRNA transport and nonsense-mediated decay. By being part of this complex MAGOH2 also aids in controlling gene expression critical for cell proliferation and differentiation.
Pathways
MAGOH2 functions in the mRNA surveillance and splicing pathways. It collaborates with related proteins such as Y14 in the exon junction complex to ensure proper gene expression post-transcription. The exon junction complex affects mRNA stability and quality control which are essential for the fidelity of genetic information. These pathways highlight the importance of MAGOH2 in maintaining efficient gene expression processes.
일반 정보
기능
Required for pre-mRNA splicing as component of the spliceosome (PubMed : 28502770, PubMed : 29301961, PubMed : 30705154). Plays a redundant role with MAGOH in the exon junction complex and in the nonsense-mediated decay (NMD) pathway (PubMed : 23917022).
서열 유사성
Belongs to the mago nashi family.
Subcellular localisation
Nucleus
타겟 정보
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com